Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K May 6, 2019 FORM 8-K
EFFECT Apr 12, 2019
DEF 14A Apr 12, 2019 DEFINITIVE PROXY STATEMENT
CORRESP Apr 10, 2019
UPLOAD Apr 8, 2019
S-3 Mar 29, 2019 FORM S-3
10-K Mar 18, 2019 10-K
10-Q/A Mar 18, 2019 10-Q/A
10-Q/A Mar 18, 2019 10-Q/A
10-Q/A Mar 18, 2019 10-Q/A
8-K Mar 18, 2019 FORM 8-K
UPLOAD Mar 15, 2019
CORRESP Mar 11, 2019
UPLOAD Feb 14, 2019
SC 13G/A Feb 12, 2019 AMENDMENT NO. 2 TO SCHEDULE 13G
SC 13G/A Feb 12, 2019 AMENDMENT NO. 3 TO SCHEDULE 13G
SC 13G/A Feb 8, 2019 SC 13G/A
8-K Feb 5, 2019 FORM 8-K
8-K Jan 10, 2019 FORM 8-K
8-K Jan 4, 2019 FORM 8-K
CORRESP Dec 27, 2018
DEFA14A Dec 19, 2018 DEFA14A
8-K Dec 17, 2018 8-K
8-K Dec 13, 2018 FORM 8-K
UPLOAD Dec 4, 2018
← Newer Page 13 of 38 · 935 filings Older →